| LDR | 01204nam a22002651a 4500 | ||
| 001 | 008515769 | ||
| 003 | MiAaHDL | ||
| 005 | 20140827000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 870129s1986 dcu f000 0 eng d | ||
| 035 | ⊔ | ⊔ | ‡asdr-pst.a373834 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)15104699 |
| 035 | ⊔ | ⊔ | ‡aLIAS462920 |
| 035 | ⊔ | ⊔ | ‡a(Sirsi) LIAS462920 |
| 040 | ⊔ | ⊔ | ‡aPSt ‡cPSt ‡dWaOLN |
| 074 | ⊔ | ⊔ | ‡a1042-A, 1042-B (microfiche) |
| 086 | 0 | ⊔ | ‡aY 4.J 89/2:S.hrg.99-948 |
| 088 | ⊔ | ⊔ | ‡aSerial no. J-99-49 (United States. Congress. Senate. Committee on the Judiciary |
| 110 | 1 | ⊔ | ‡aUnited States. ‡bCongress. ‡bSenate. ‡bCommittee on the Judiciary. |
| 245 | 1 | 0 | ‡aControlled Substance Analogs Enforcement Act of 1985 : ‡bhearing before the Committee on the Judiciary, United States Senate, Ninety-ninth Congress, first session on S. 1437 ... September 18, 1985. |
| 260 | ⊔ | ⊔ | ‡aWashington : ‡bU.S. G.P.O. : ‡bFor sale by Supt. of Docs., U.S. Govt. Print. Office, Congressional Sales Office, ‡c1986. |
| 300 | ⊔ | ⊔ | ‡aiii, 81 p. : ‡bill. ; ‡c24 cm. |
| 490 | 0 | ⊔ | ‡aS. hrg. ; 99-948 |
| 500 | ⊔ | ⊔ | ‡a"Serial no. J-99-49". |
| 504 | ⊔ | ⊔ | ‡aIncludes bibliographical references. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aDrugs ‡xLaw and legislation ‡zUnited States. |
| CID | ⊔ | ⊔ | ‡a008515769 |
| DAT | 0 | ⊔ | ‡b20140827000000.0 |
| DAT | 1 | ⊔ | ‡a20140828090741.0 ‡b2024-01-20T19:03:04Z |
| DAT | 2 | ⊔ | ‡a2024-01-20T18:30:02Z |
| CAT | ⊔ | ⊔ | ‡aSDR-PST ‡dUNKNOWN ‡lloader.pl-003-018 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-pst.a373834 ‡apst ‡bSDR ‡cPST ‡ppst.000011992523 ‡sPST ‡z4.J 89/2:S.hrg.99-948 ‡1a373834 |
| 974 | ⊔ | ⊔ | ‡bPST ‡cPST ‡d20240120 ‡sgoogle ‡upst.000011992523 ‡z4.J 89/2:S.hrg.99-948 ‡y1986 ‡rpd ‡qbib ‡tUS fed doc |